Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38831

DKK1 Knockout HGC-27 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Stomach

  • Disease:

    Carcinoma

The DKK1 Knockout HCT 116 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of HCT 116 colorectal carcinoma cells with targeted disruption of the DKK1 gene. DKK1 encodes a secreted Wnt antagonist that binds LRP5/6 co-receptors and Kremen proteins to inhibit ??-catenin signaling. Disruption of DKK1 in the constitutively active CTNNB1-mutant HCT 116 background allows dissection of feedback regulation and non-canonical Wnt outputs. This model is applicable to Wnt pathway analysis, colorectal cancer oncogenesis studies, drug screening, and metastasis research.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HGC-27

    Sex of Donor

    Unknown

    Age

    Unknown

    Derived From Site

    Metastatic; Lymph node

    Gene Name

    DKK1

    Gene Identifier

    NCBI Gene ID 22943

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DKK1 Knockout HCT 116 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal population of HCT 116 human colorectal carcinoma cells harboring targeted disruption of the DKK1 gene. This knockout pool retains the inherent heterogeneity of polyclonal editing, offering a genetically diverse loss-of-function model for studying DKK1-dependent signaling processes. The knockout population eliminates expression of the secreted Wnt antagonist Dickkopf-related protein 1 (DKK1), thereby relieving its inhibitory constraints on Wnt/??-catenin and associated pathways.

HCT 116 is a widely employed human colorectal carcinoma epithelial cell line derived from a male colorectal adenocarcinoma. These cells harbor a heterozygous deletion of serine 45 in the CTNNB1 gene (S45del), which stabilizes ??-catenin and drives constitutive TCF/LEF-mediated transcription independent of Wnt ligand stimulation. This genetic background makes HCT 116 a foundational model for investigating canonical Wnt/??-catenin signaling, tumor cell proliferation, and oncogenic transformation in colorectal cancer.

DKK1 functions as a high-affinity antagonist by forming a ternary complex with LRP5/6 co-receptors and Kremen1/2 transmembrane proteins, triggering clathrin-mediated endocytosis and removal of LRP5/6 from the cell surface, thereby impeding Wnt?CFrizzled?CLRP5/6 signalosome assembly. This activity suppresses ??-catenin stabilization and TCF/LEF-dependent transcription of target genes such as MYC, CCND1, and AXIN2. DKK1 expression is itself regulated by TCF/LEF, p53, and BMP-2, and it reciprocally modulates BMP and TGF-?? signaling. In parallel, DKK1 influences non-canonical Wnt/PCP outputs through its interactions with Wnt ligands and Dishevelled family members.

In HCT 116 cells, the S45del CTNNB1 mutation partially uncouples ??-catenin signaling from upstream Wnt ligand input; however, DKK1-mediated feedback inhibition still operates on residual ligand-dependent nuances and non-canonical branches. Disruption of DKK1 in this background eliminates a critical endogenous brake, potentially augmenting TCF/LEF transcriptional activity and altering the balance between canonical and non-canonical Wnt signaling. The knockout model may exhibit altered expression of direct ??-catenin targets like MYC and AXIN2, and altered activation of JNK cascades downstream of planar cell polarity components, providing a tool to dissect Wnt pathway crosstalk in a mutationally defined colorectal cancer context.

This polyclonal DKK1 knockout cell pool is suited for a broad range of experimental applications, including Wnt pathway reporter assays (TOPFlash/FOPFlash), RT-qPCR profiling of downstream targets (AXIN2, MYC, CCND1), and Western blot analysis of ??-catenin stabilization and c-MYC induction. Researchers can employ the model in drug screening campaigns for novel Wnt inhibitors, in co-culture systems examining tumor?Cstroma interactions, or in functional assays measuring clonogenic growth, Transwell migration, and apoptosis. Additionally, DKK1??s role in osteolytic bone disease and stem cell differentiation makes this knockout resource valuable for investigating metastatic colonization and developmental signaling. For detailed technical support and custom requests, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)